|Videos|September 13, 2016

Canine lymphoma update

You may have heard it's coming, and now it's here: monoclonal antibody therapy to assist in the treatment of lymphoma in your canine veterinary patients.

Cancer. One word guaranteed to sober any veterinary exam room. But a new weapon of mass destruction just aimed its sights on one of the most common forms of canine cancer, lymphoma, as veterinary oncologist Dr. Sue Ettinger told us at CVC Virginia Beach in May. Used in conjunction with chemotherapy, monoclonal antibody therapy (e.g. Blontress-Aratana) flags cancer cells so the dog's immune system can attack them. Hear more:

Newsletter

From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.

Subscribe Now!

Related Content